Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Multicenter, Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap.
for Comparative Evaluation of Safety & Efficacy in Rheumatoid Arthritis Patients